ALEXANDRIA, Va., April 25, 2017 /PRNewswire/ -- Appian360 Healthcare Innovations ("Appian360") and Cordata Healthcare
"We are pleased to partner with Cordata and its care coordination and patient engagement system, which we believe to be the best-in-class," said Stan Grice, Co-Founder, CEO and President of Appian360. "Our solution will allow doctors to standardize care paths in order to quickly identify and manage at-risk patients, empower care teams to implement and track care plans, engage patients in care management and provide improved communication with patients and their families."
"With Appian360's Algorithm Generator™, oncology care teams can now create standardized diagnostic and other pathways informed by current standards and evidence-based knowledge," said Robert Bridwell, MD, MBA, Appian360's Co-Founder and Chief Medical Officer. "We are building the next-generation care coordination and patient engagement platform for people with cancer."
The use of Cordata will help ensure that patients are engaged and motivated to stick to treatment plans, take the right steps at the right time along their care paths, and navigate the unique challenges of oncology care from screening to survivorship. Hospitals and providers will also benefit from the capture of better data about outcomes.
Additional platform enhancements include Roadmaps to provide a longitudinal view of care over time, the AcuSym™ system to manage disease specific symptoms, features to address co-morbidities with severity/acuity indexing at diagnosis, and analytics to proactively monitor patient satisfaction and measure care outcomes.
"Early, accurate and comprehensive diagnosis is the foundation of effective care for people with cancer. Fundamentally, the combination of care coordination and clinical algorithms can promote better outcomes for both patients and providers," says Gary Winzenread, CEO and President of Cordata Healthcare Innovations. "This partnership between Appian360 and Cordata will help the oncology service line by improving clinical and financial outcomes in the near-term, while paving the way for smooth transitions to value-based care in the long term."
About Appian360 Healthcare Innovations:
Appian360 is a physician-led oncology pathways company focused on solving today's most complex health management challenges. We aim to reduce clinical variability among the care management team, lower costs, improve diagnostic accuracy, increase patient retention and adherence and make outcomes more accountable, measurable and predictable. Using the Appian 360 Algorithm Generator™, health systems and physicians create consensus-driven standardized pathways that are informed by current guidelines and evidence-based knowledge through a secure, interoperable patient-centered care coordination platform. The platform helps medical, radiation and surgical oncology providers and care teams to decrease administrative burden and embed quality endpoints while optimizing patient engagement. Learn more at www.appian360.com
About Cordata Healthcare Innovations:
Cordata's specialty care coordination platform helps healthcare organizations more effectively treat people with chronic specialty diseases and generate better clinical and business outcomes through effective patient management and retention along complex care paths. Physicians, nurse navigators, service-line directors and business executives at 100+ hospitals and health systems rely on Cordata for timely and actionable insights. Learn more at www.cordatahealth.com
Contact: Dan Dyer Tier 1 Public Relations513-478-7818 [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/appian360-and-cordata-healthcare-to-provide-a-single-patient-centered-oncology-care-platform-300445016.html
SOURCE Cordata Healthcare Innovations
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All